Common use of Permitted Use and Disclosures Clause in Contracts

Permitted Use and Disclosures. Each Party may use or disclose Confidential Information disclosed to it by the other Party or Results to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b)), prosecuting or defending litigation, complying with applicable governmental laws, regulations or court order or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party to it pursuant to the terms of this Agreement, provided that if a Party is required by governmental authority to make any such disclosure, other than pursuant to a confidentiality agreement, it shall give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of patent applications, shall use its reasonable efforts to secure confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party hereto may (i) use Confidential Information disclosed to it by the other in conducting the Research Program and (ii) use or disclose Confidential Information disclosed to it by the other Party or Results party, to the extent such information is within the Program Technology and such use or disclosure is reasonably necessary and permitted in (A) the exercise of the such rights granted hereunder hereunder, (including Juno’s development and commercialization of ProductsB) and in filing or prosecuting patent applications applications, (subject to Section 8.1(b)), C) prosecuting or defending litigation, (D) complying with applicable governmental laws, regulations or court order or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or (E) making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party to it party pursuant to the terms of this Agreement, ; provided that if a Party party is required by governmental authority to make any such disclosure, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice to the other Party party of such disclosure and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable best efforts to secure confidential treatment of such information in consultation with the other Party party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party Notwithstanding the restrictions of Section 6.1, each party hereto may (a) use Confidential Information disclosed to it by the other to the extent necessary for that party to perform its obligations set forth in the CDP and (b) use or disclose Confidential Information disclosed to it by the other Party or Results party to the extent such use or disclosure is reasonably necessary and permitted in the exercise of (i) exercising the rights and licenses granted hereunder hereunder, (including Juno’s development and commercialization of Productsii) and in filing or prosecuting patent applications (subject to Section 8.1(b)), prosecuting or defending litigation, (iii) complying with applicable governmental laws, governmental regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per authorities (including the rules of any securities exchange or similar organization, conducting clinical trialsSecurities and Exchange Commission), or making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party to it pursuant to the terms of this Agreement(iv) preparing, filing and prosecuting patent applications; in each case, provided that if a Party party is required by governmental authority to make any such disclosure, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice to the other Party party of such disclosure and, save to the extent inappropriate in the case of patent applications, shall and will use its reasonable efforts to secure confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders order or otherwise) and ), except to the extent inappropriate with respect to patent applications. It is understood that either party may also disclose only the minimum necessary Confidential Information of the other party upon receipt of the written consent to comply with such requirementsdisclosure by a duly authorized representative of the other party.

Permitted Use and Disclosures. Each Party party hereto may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Aurora Technology, Allelix Technology or Results Joint Technology, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement, provided that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose the other party’s Confidential Information disclosed to it by the other Party extent such information is included in the Ajinomoto Technology, Senomyx Technology or Results Joint Inventions, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and hereunder, in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsor stock exchange regulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organizationconducting taste testing, conducting clinical trialssubmitting information for regulatory applications, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party’s Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Aurora Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental laws, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Xxxxxxxx Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, submitting information for food additive approval applications, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Nestlé Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, submitting information for food additive approval applications, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party party, and will request the prior approval of the other party (such approval not to be unreasonably withheld) Where any such disclosure andof Confidential Information is approved, save to the extent inappropriate in the case of patent applications, shall use its reasonable efforts to secure that party disclosing confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and will disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Kraft Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, submitting information for food additive approval applications, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party hereto may use or disclose Confidential Information ----------------------------- information disclosed to it by the other Party party to the extent such information is included in the Licensed Technology or Results the BMS Technology, as the case may be, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the such rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental laws, regulations or court order or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party party to it pursuant to the terms of this Agreement, provided that if a Party party is required by governmental authority to make any such disclosure, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice to the other Party party of such disclosure and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information in consultation with the other Party party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party hereto may use or disclose Confidential Information information disclosed to it by the other Party to the extent such information is included in the Licensed Technology, the Teijin Technology or Results the Teijin Know-How, as the case may be, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the such rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental laws, regulations or court order or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party to it pursuant to the terms of this Agreement, provided that if a Party is required by governmental authority to make any such disclosuredisclosure of another Party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable best efforts to secure confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements. *** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Solae Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organizationconducting taste testing, conducting clinical trialssubmitting information for regulatory applications, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party’s Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Kraft Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, [...***...], or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party hereto may use or disclose Confidential Information disclosed to it by of the other Party or Results to the extent such use or disclosure is reasonably necessary and permitted (a) in the exercise of the rights granted or reserved to it hereunder (including Juno’s development permitted licensees or sublicenses) on the condition that any Affiliate or Third Party to whom it is disclosed agrees to be bound by confidentiality and commercialization of Productsnon-use obligations substantially similar to those contained in this Agreement; or (b) and in filing prosecuting patents or prosecuting patent applications to gain approval to conduct clinical trials or to market Product, but such disclosure may be only to the extent reasonably necessary to obtain patents or authorizations from governmental or other regulatory agencies; or (subject to Section 8.1(b)), c) in prosecuting or defending litigation, complying with applicable governmental laws, regulations or court order or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party to it pursuant to the terms of this Agreement, ; provided that if a Party is required by governmental authority law to make any such disclosure, other than pursuant to a confidentiality agreement, it shall give reasonable advance notice to will promptly notify the other Party of such disclosure in order to provide the other Party an opportunity to challenge or limit the disclosure obligations and, save to the die extent inappropriate in the case of patent applicationsapplications or the like, shall will use its reasonable efforts to secure confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party hereto may use or disclose Confidential Information disclosed to it by the other Party or Results party only to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the such rights granted hereunder (including Juno’s development and commercialization of Productsi) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, or prosecuting or defending litigation, (ii) complying with applicable governmental laws, regulations or a court order or otherwise order, (iii) submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, (iv) conducting clinical trials, or (v) making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party party to it pursuant to the terms of this Agreement; provided, provided that if a Party party is required by governmental authority to make any such disclosuredisclosure of another party's Confidential Information, other than pursuant to a confidentiality agreementagreement which protects such Confidential Information substantially to the same extent as set forth herein, it shall such party will give reasonable advance notice to the other Party party of such disclosure and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable best efforts to secure confidential treatment of such information in consultation with the other Party party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party hereto may use or disclose Confidential Information disclosed to it by of the other Party or Results to the extent such use or disclosure is reasonably necessary and permitted (a) in the exercise of the rights granted or reserved to it hereunder (including Juno’s development permitted licensees or sublicenses) on the condition that any Affiliate or Third Party to whom it is disclosed agrees to be bound by confidentiality and commercialization of Productsnon-use obligations substantially similar to those contained in this Agreement; or (b) and in filing prosecuting patents or prosecuting patent applications to gain approval to conduct clinical trials or to market Product, but such disclosure may be only to the extent reasonably necessary to obtain patents or authorizations from governmental or other regulatory agencies; or (subject to Section 8.1(b)), c) in prosecuting or defending litigation, complying with applicable governmental laws, regulations or court order or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party to it pursuant to the terms of this Agreement, ; provided that if a Party is required by governmental authority law to make any such disclosure, other than pursuant to a confidentiality agreement, it shall give reasonable advance notice to will promptly notify the other Party of such disclosure in order to provide the other Party an opportunity to challenge or limit the disclosure obligations and, save to the extent inappropriate in the case of patent applicationsapplications or the like, shall will use its reasonable efforts to secure confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party hereto may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Aurora Technology, Cytovia Technology or Results Joint Technology, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement, provided that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party's Confidential Information, other than pursuant ***Confidential Treatment Requested 20 to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party hereto may use or disclose Confidential Information information disclosed to it by the other Party to the extent such information is included in the Licensed Technology, the Teijin Technology or Results the Teijin Know-How, as the case may be, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the such rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental laws, regulations or court order or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by the other Party to it pursuant to the terms of this Agreement, provided that if a Party is required by governmental authority to make any such disclosuredisclosure of another Party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable best efforts to secure confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Nestlé Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, submitting information for regulatory approval applications, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party’s Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party party and will request the prior approval of the other party (such approval not to be unreasonably withheld). Where any such disclosure andof Confidential Information is approved, save to the extent inappropriate in the case of patent applications, shall use its reasonable efforts to secure confidential treatment of such information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and that party disclosing Confidential Information will disclose only the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Firmenich Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental lawsregulations, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organizationconducting taste testing, conducting clinical trialssubmitting information for regulatory applications, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; provided, provided however, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party’s Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only ). Any disclosure of Confidential Information shall be limited to the minimum necessary to comply with such requirements.

Permitted Use and Disclosures. Each Party party may use or disclose Confidential Information disclosed to it by the other Party party to the extent such information is included in the Aurora Technology, Senomyx Technology or Results Joint Patent Rights, and to the extent such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder (including Juno’s development and commercialization of Products) and in filing or prosecuting patent applications (subject to Section 8.1(b))applications, prosecuting or defending litigation, complying with applicable governmental laws, regulations or court order orders or otherwise submitting information to tax or other governmental authorities, per the rules of any securities exchange or similar organization, conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted by to the other Party to it party pursuant to the terms of this Agreement; PROVIDED, provided HOWEVER, that if a Party party is required by governmental authority to make any such disclosuredisclosure of the other party's Confidential Information, other than pursuant to a confidentiality agreement, it shall will give reasonable advance notice of such disclosure to the other Party of such disclosure party where reasonably possible and, save to the extent inappropriate in the case of patent applications, shall will use its reasonable efforts to secure confidential treatment of such information Confidential Information in consultation with the other Party party prior to its such disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.